The Life Sciences Investment Programme (LSIP) is a £200m initiative managed by British Business Bank designed to address the growth equity finance gap faced by high-potential UK life sciences companies. This is expected to attract at least a further £400m of private investment.
Through LSIP, we make cornerstone commitments to later stage life sciences venture growth funds with a strong UK focus, typically investing between £50m and £100m in each successful fund.
Key features
- Dedicated life sciences focus
- Funds providing later-stage capital
- UK presence in investment team
- Minimum target fund size of £250m
- Focus on funding UK companies
Find out more
For further information please see our Request for Proposals.
If you have any queries please contact [email protected].
Related articles
Is mezzanine finance right for your business?
Read article Is mezzanine finance right for your business?
What is a Cap table?
Read article What is a Cap table?
What is export insurance and how can I use it?
Read article What is export insurance and how can I use it?
Sign up for our newsletter
Just add your details to receive updates and news from the British Business Bank
Sign up to our newsletter